67 cases on record
- Cases on record
- 67
- Classification
- C07D487/04 · A61K31/519 · A61K31/365 · A61K31/445 · A61K38/13 · A61K45/06 · A61P1/00 · A61P1/04 · A61P3/10 · A61P11/06 · A61P17/00 · A61P17/06 · A61P19/02 · A61P25/28 · A61P29/00 · A61P35/00 · A61P35/02 · A61P37/00 · A61P37/06 · A61P43/00 · C07D487/02 · C07D471/04 · A61K31/42 · A61K31/41 · H10P95/00 · C07D401/14 · A61K31/675 · A61K31/444 · A61K31/5377 · A61K31/551 · A61P9/10 · A61P13/12 · A61P15/00 · A61P25/00 · A61P31/10 · A61P31/12 · A61P31/18 · A61P31/22 · C07F9/6561 · C07D401/06 · C12Q1/66 · C07D519/00 · A61K49/00 · C09K11/06 · C07D401/12 · C07C55/10 · C07D213/74 · C07D213/73 · C07D239/42 · C07D215/22 · C07D215/233 · A61K9/20 · C07C51/41 · C07D417/04 · C07B59/00 · A61K9/00 · A61K31/573 · A61P35/04 · C07D471/22 · A61K31/351 · A61K31/4412 · C07D487/22 · C07D498/14 · C07D267/22 · C07D281/18 · C07D291/00 · C07D337/16 · C07D487/00 · C07D498/22 · A61K31/395 · A61P31/04 · C07D271/06 · C07D413/04 · C07D413/14 · C07D265/12 · C07D401/04 · C07D405/04 · C07D498/18 · A61K31/513 · A61K31/553 · A61K31/683 · A61K31/537 · A61K31/685 · C07D487/14 · A61K31/4985 · A61K47/12 · A61K47/38 · A61K31/397 · C07D263/57 · A61K31/423 · C07D239/54 · A61K31/4245 · A61K · A61K31/03 · A61K31/055 · A61K31/192 · C07D263/56 · C07K1/00 · G01N33/50 · G01N33/53 · G01N33/567 · G01N33/68 · C07D271/07 · A61K45/00 · A61P9/00 · C07D239/47 · A61K31/506 · A61K31/505 · A61P3/06 · A61P7/06 · A61P9/04 · A61P9/12 · A61P13/08 · A61P15/10 · A61P25/04 · A61P25/06 · A61P27/02 · A61P27/06 · A61P27/16 · C07D239/46 · C07D239/52 · C07D239/56 · C07D239/60 · C07D403/04 · C07D403/12 · C07D403/14 · C07D405/12 · C07D405/14 · C07D407/14 · C07D409/14 · C07D417/14 · C07D223/16 · C07D235/06 · A61K47/02 · A61K47/26 · C30B7/08 · C30B29/54 · C07D235/08 · A61K31/515 · C07D241/18 · A61P7/02 · A61P9/08 · C07D241/20 · A61K31/53 · C07D253/065 · A61K31/4418 · A61K31/4965 · A61K31/497 · A61P11/08 · A61P17/02 · A61P37/02 · A61P37/08 · C07D241/12 · C07D253/07 · C07D409/12 · C07D231/38 · A61P9/02 · A61P13/00 · A61P19/10 · A61P25/16 · A61P25/24 · C07D239/02 · A61K31/437 · A61K31/47 · A61K31/549 · C07D215/14 · C07D261/14 · C07D285/16 · A61K31/4439 · C07D213/76 · C07D239/49 · C07D231/40 · C07D285/135 · A61K31/415 · A61K31/433 · A61K31/4436 · A61K31/4545 · C07D213/72 · C07D285/12 · C07D261/04 · A01N43/54 · A61K31/44 · C07D213/75 · C07D213/82 · C07D215/12 · C07D215/20 · C07D215/38 · C07D239/48 · C07D263/48 · C07D417/12 · C07D295/26 · C07D307/00 · C07D239/00 · C07D213/00 · C07D307/52 · C07D307/90 · C07D277/46 · C07D277/00 · C07D295/00 · C07D307/12 · C07D493/04 · C07D407/06 · C07F7/18 · C07D493/08 · C07D307/33 · C07D307/28 · C07D493/18 · C07D493/22 · C07D493/20 · C07D317/72 · C07H15/26 · C07C33/42 · A61K31/341 · C07D493/10 · C07D401/00 · A61K31/4184 · A61K31/4375 · A61P31/14 · C07K5/078 · C07K5/097 · A61K38/00 · C07D277/56 · C07D417/02 · A61K31/426 · C07D487/08 · A61K31/496 · A61P19/04 · A61P29/02 · C07D295/096 · C07D241/04 · C07D243/08 · C07D211/20 · C07D211/70 · A61K31/451 · A61K31/495 · A61P25/18 · A61P25/22 · C07D211/24 · C07D295/08
- Courts involved
- D. Del. · D.N.J. · Fed. Cir. · N.D. Ill. · S.D. Iowa · D. Mass. · D. Minn. · Court of Justice of Sao Paulo
| Case no. | Parties | Court | Filed | Duration | Outcome |
|---|---|---|---|---|---|
| 1:25-cv-01202 | Pfizer, Inc. v. Prinston Pharmaceutical, Inc. | D. Del. | 26 Sep 2025 | 7 d | Voluntary dismissal |
| 1:25-cv-00857 | Janssen Pharmaceuticals, Inc. v. Sun Pharmaceutical Industries, Inc. | D. Del. | 10 Jul 2025 | 110 d | Voluntary dismissal |
| 1:25-cv-00775 | Pfizer, Inc. v. Apotex, Inc. | D. Del. | 23 Jun 2025 | 119 d | Dismissed without Prejudice |
| 1:25-cv-00765 | Pfizer, Inc. v. Apotex, Inc. | D. Del. | 20 Jun 2025 | 42 d | Dismissed without Prejudice |
| 1:25-cv-00632 | Pfizer, Inc. v. Macleods Pharmaceuticals | D. Del. | 21 May 2025 | 55 d | Dismissed without Prejudice |
| 1:25-cv-00617 | Pfizer, Inc. v. Somerset Therapeutics LLC | D. Del. | 16 May 2025 | 138 d | Dismissed without Prejudice |
| 1:25-cv-00565 | Pfizer, Inc. v. Alkem Laboratories, Ltd. | D. Del. | 7 May 2025 | 44 d | Dismissed without Prejudice |
| 2:25-cv-02020 | Eli Lilly & Company v. Humanwell Pharmaceutical US, Inc. | D.N.J. | 21 Mar 2025 | 201 d | Case Dismissed |
| 1:25-cv-00244 | Promega Corporation v. Aobious Inc. | D. Del. | 3 Mar 2025 | 134 d | Consent Judgment |
| 1:24-cv-01427 | Pfizer, Inc. v. Alkem Laboratories, Ltd. | D. Del. | 30 Dec 2024 | 64 d | Dismissed without Prejudice |
| 1:24-cv-01367 | Novartis, AG v. Natco Pharma, Ltd. | D. Del. | 13 Dec 2024 | 139 d | Dismissed with Prejudice |
| 25-1241 | Exelixis, Inc. v. MSN Laboratories Private, Ltd. | Fed. Cir. | 3 Dec 2024 | 189 d | Appeal Dismissed |
| 2:24-cv-10802 | Eli Lilly & Company v. Qilu Pharmaceutical Co., Ltd. | D.N.J. | 27 Nov 2024 | 21 d | Case Consolidated |
| 25-1162 | Sun Pharmaceutical Industries, Inc. v. Incyte Corporation | Fed. Cir. | 12 Nov 2024 | 176 d | Case Reversed |
| 1:24-cv-01189 | ViiV Healthcare, Co. v. Hetero USA, Inc. | D. Del. | 23 Oct 2024 | 49 d | Consent Judgment |
| 1:24-cv-01122 | Pfizer, Inc. v. Breckenridge Pharmaceutical, Inc. | D. Del. | 9 Oct 2024 | 35 d | Dismissed without Prejudice |
| 1:24-cv-09441 | Janssen Products, LP v. EVER Valinject GmbH | N.D. Ill. | 3 Oct 2024 | 141 d | Case Terminated |
| 1:24-cv-09512 | Salix Pharmaceuticals, Inc. v. Zydus Cadila | D.N.J. | 27 Sep 2024 | 325 d | Dismissed without Prejudice |
| 1:24-cv-01033 | Novartis, AG v. Natco Pharma, Ltd. | D. Del. | 13 Sep 2024 | 230 d | Dismissed with Prejudice |
| 1:24-cv-00927 | Pfizer, Inc. v. SpecGx, LLC | D. Del. | 9 Aug 2024 | 95 d | Dismissed without Prejudice |
| 1:24-cv-00780 | Bristol-Myers Squibb v. Synthon, BV | D. Del. | 2 Jul 2024 | 440 d | Dismissed without Prejudice |
| 24-2020 | Janssen Pharmaceuticals, Inc. v. Tolmar, Inc. | Fed. Cir. | 28 Jun 2024 | 676 d | Case Remanded |
| 1:24-cv-00757 | Pfizer, Inc. v. Biocon, Ltd. | D. Del. | 26 Jun 2024 | 75 d | Dismissed without Prejudice |
| 24-1980 | Tolmar, Inc. v. Janssen Pharmaceuticals, Inc. | Fed. Cir. | 21 Jun 2024 | 683 d | Case Remanded |
| 1:24-cv-00657 | ViiV Healthcare, Co. v. Hetero USA, Inc. | D. Del. | 3 Jun 2024 | 191 d | Consent Judgment |
| 1:24-cv-00547 | ViiV Healthcare, Co. v. Hetero USA, Inc. | D. Del. | 3 May 2024 | 222 d | Consent Judgment |
| 24-1699 | Tolmar, Inc. v. Janssen Pharmaceuticals, Inc. | Fed. Cir. | 16 Apr 2024 | 749 d | Case Remanded |
| 24-1700 | Janssen Pharmaceuticals, Inc. v. Tolmar, Inc. | Fed. Cir. | 16 Apr 2024 | 749 d | Case Remanded |
| 3:24-cv-01971 | Beigene USA, Inc. v. Msn Pharmaceuticals, Inc. | D.N.J. | 8 Mar 2024 | 256 d | Dismissed without Prejudice |
| 4:24-cv-00055 | FMC Technologies, Inc. v. Albaugh, LLC | S.D. Iowa | 12 Feb 2024 | 280 d | Dismissed with Prejudice |
| 1:23-cv-01480 | Gilead Sciences, Inc. v. Cipla Limited | D. Del. | 29 Dec 2023 | 647 d | Case Consolidated |
| 1:23-cv-01332 | AbbVie, Inc. v. Hetero USA, Inc. | D. Del. | 20 Nov 2023 | 662 d | Dismissed without Prejudice |
| 1:23-cv-01277 | Eli Lilly & Company v. MSN Laboratories Private Limited | D. Del. | 8 Nov 2023 | 191 d | Case Consolidated |
| 1:23-cv-00924 | Pfizer, Inc. v. Zenara Pharma Private, Ltd. | D. Del. | 23 Aug 2023 | 979 d | Dismissed without Prejudice |
| 1:23-cv-00892 | AbbVie, Inc. v. Zenara Pharma Private, Ltd. | D. Del. | 11 Aug 2023 | 68 d | Dismissed without Prejudice |
| 1:23-cv-00879 | Pfizer, Inc. v. Dexcel Pharma Technologies Limited | D. Del. | 10 Aug 2023 | 992 d | Dismissed without Prejudice |
| 3:23-cv-04152 | Azurity Pharmaceuticals, Inc. v. Cadila Healthcare, Ltd. | D.N.J. | 3 Aug 2023 | 125 d | Voluntary dismissal |
| 1:23-cv-00734 | Actelion Pharmaceuticals, Ltd. v. Apotex, Inc. | D. Del. | 6 Jul 2023 | 84 d | Consent Judgment |
| 1:23-cv-00710 | Otsuka Pharmaceutical Co., Ltd. v. Apotex, Inc. | D. Del. | 30 Jun 2023 | 89 d | Consent Judgment |
| 1:23-cv-00717 | Pfizer, Inc. v. Aurobindo Pharma, Ltd. | D. Del. | 30 Jun 2023 | 168 d | Dismissed without Prejudice |
| 1:23-cv-00718 | Pfizer, Inc. v. Sun Pharmaceutical Industries, Inc. | D. Del. | 30 Jun 2023 | 56 d | Dismissed without Prejudice |
| 1:23-cv-00684 | AbbVie, Inc. v. Sun Pharmaceutical Industries, Inc. | D. Del. | 23 Jun 2023 | 364 d | Dismissed without Prejudice |
| 1:23-cv-00634 | Pfizer, Inc. v. Annora Pharma Private, Ltd. | D. Del. | 9 Jun 2023 | 77 d | Dismissed without Prejudice |
| 1:23-cv-00625 | Array BioPharma, Inc. v. Teva Pharmaceutical Industries, Ltd. | D. Del. | 8 Jun 2023 | 785 d | Dismissed without Prejudice |
| 2:23-cv-02364 | Merck Sharp & Dohme, LLC v. Hetero USA, Inc. | D.N.J. | 28 Apr 2023 | 172 d | Injunction Granted |
| 1:23-cv-01961 | Catalyst Pharmaceuticals, Inc. v. MSN Laboratories Private Limited | D.N.J. | 6 Apr 2023 | 112 d | Case Consolidated |
| 1:23-cv-01945 | Catalyst Pharmaceuticals, Inc. v. MSN Laboratories Private Limited | D.N.J. | 5 Apr 2023 | 450 d | Consent Judgment |
| 1:23-cv-00383 | Actelion Pharmaceuticals US, Inc. v. Alembic | D. Del. | 4 Apr 2023 | 92 d | Injunction Granted |
| 2:23-cv-01285 | Adverio Pharma GmbH v. Alembic Pharmaceuticals Limited | D.N.J. | 7 Mar 2023 | 254 d | Case Terminated |
| 2:22-cv-07454 | Takeda Pharmaceuticals America, Inc. v. Teva Pharmaceuticals, Inc. | D.N.J. | 21 Dec 2022 | 251 d | Consent Judgment |
| 23-1113 | Novartis, AG v. Plexxikon, Inc. | Fed. Cir. | 2 Nov 2022 | 420 d | Voluntary dismissal |
| 2:22-cv-06104 | Adverio Pharma GmbH v. Alembic | D.N.J. | 17 Oct 2022 | 395 d | Case Terminated |
| 2:22-cv-05950 | Eisai v. Dr. Reddy's Laboratories, Ltd. | D.N.J. | 7 Oct 2022 | 396 d | Case Dismissed |
| 3:22-cv-05950 | Eisai Co., Ltd. v. Dr. Reddy | D.N.J. | 7 Oct 2022 | 327 d | Case Transferred |
| 1:22-cv-01316 | Array BioPharma, Inc. v. Sandoz, Inc. | D. Del. | 6 Oct 2022 | 826 d | Dismissed without Prejudice |
| 1:22-cv-01291 | Neurocrine Biosciences, Inc. v. Zydus Cadila | D. Del. | 30 Sep 2022 | 409 d | Dismissed without Prejudice |
| 1:22-cv-01277 | Array BioPharma, Inc. v. Alembic | D. Del. | 28 Sep 2022 | 986 d | Dismissed without Prejudice |
| 1:22-cv-01114 | Eli Lilly & Company v. Aurobindo Pharma, Ltd. | D. Del. | 24 Aug 2022 | 632 d | Dismissed without Prejudice |
| 1:22-cv-10967 | Enanta Pharmaceuticals, Inc. v. Pfizer, Inc. | D. Mass. | 21 Jun 2022 | 958 d | Judgment on the merits for Defendant |
| 0:22-cv-01283 | Bristol-Myers Squibb v. Nanocopoeia, LLC | D. Minn. | 10 May 2022 | 527 d | Case Dismissed |
| 1:22-cv-00092 | Neurocrine Biosciences, Inc. v. Teva Pharmaceutical Industries, Ltd. | D. Del. | 21 Jan 2022 | 432 d | Consent Judgment |
| 1:21-cv-01561 | ViiV Healthcare, Co. v. Lupin Limited | D. Del. | 2 Nov 2021 | 497 d | Consent Judgment |
| 1:21-cv-01043 | Neurocrine Biosciences, Inc. v. Teva Pharmaceutical Industries, Ltd. | D. Del. | 16 Jul 2021 | 621 d | Case Consolidated |
| 1:21-cv-00981 | Novartis, AG v. Msn Pharmaceuticals, Inc. | D. Del. | 1 Jul 2021 | 1314 d | Dismissed with Prejudice |
| 1:21-cv-00870 | Novartis, AG v. Fresenius Kabi | D. Del. | 17 Jun 2021 | 1328 d | Dismissed with Prejudice |
| 19-2011 | Concert Pharmaceuticals, Inc. v. Incyte Corporation | Fed. Cir. | 12 Jun 2019 | 1532 d | Appeal Dismissed |
| 2114669-32.2023.8.26.0000 | Lundbeck, Ltd. v. Althaia S A Industria Farmaceutica | Court of Justice of Sao Paulo | – | Appeal Dismissed |
Source: Patsnap Litigation Data. Cases classified under Heterocyclic Compounds.
Run this in Eureka
Patsnap Eureka
Where the claim space is crowded
Which patents are asserted most in this field, and which branches are still open.
Map this field10,000 free credits to start
Heterocyclic Compounds
Map this dispute space
- 01Ranked prior artEvery hit source-linked
- 02Claim-level comparisonAgainst your own product
- 03Legal statusAcross 174 jurisdictions
Disclaimer. This page indexes publicly available court docket data and is provided for general information and reference only. It is not legal advice and must not be relied upon as such.
Coverage has limits. Records come from a snapshot and may lag live dockets. Sealed filings, amended complaints and post-closure motions may not be reflected, and a case missing from this list is not evidence that it does not exist. Counts on this page describe what the snapshot contains, nothing more.
No characterisation of any party. Appearing on this page means a party is named in a docket record. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, or that any party prevailed.